Hypertension and the risk of cancer: Is there new evidence?

Journal of Hypertension

Volumn 20, Issue 4, 2002, Pages 565-567

  Stumpe, Klaus O ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ATENOLOL; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; RAUWOLFIA EXTRACT; RESERPINE;

ADULT; BREAST CANCER; CANCER MORTALITY; CANCER RISK; CANCER SUSCEPTIBILITY; COLON CANCER; HUMAN; HYPERTENSION; KIDNEY CARCINOMA; LUNG CANCER; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SHORT SURVEY;

EID: 0036528846     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200204000-00003     Document Type: Short Survey

References (42)

1. Cancer and hypertension, an unresolved issue
2. On the bimodal age distribution of mammary carcinoma
3. Reserpine and breast cancer
4. Retrospective study of the association between use of rauwolfia derivatives and breast cancer in English women
5. Reserpine use in relation to breast cancer
6. High blood-pressure: A risk factor for cancer mortality?
7. Mortality and morbidity during 13.5 years' follow-up in relation to blood pressure
8. High blood pressure and 17-year cancer mortality in the Western Electric health study
9. Systolic blood pressure and cancer mortality in an elderly population
10. Elevated systolic blood pressure as a predictor of long-term cancer mortality: Analysis by site and histologic subtype in 10 000 middle-aged and elderly men
11. Cancer incidence in hypertensives
12. The association of blood pressure with cancer incidence in a prospective study
13. Blood pressure and mortality risk in the elderly
14. Blood pressure and mortality: An epidemiological survey with 10 years follow-up
15. Blood pressure and cancer in middle-aged British men
16. Hypertension, antihypertensive drugs and mortality from cancer among women
17. Hypertension and breast cancer risk in a 19-year follow-up study (the DOM cohort)
18. The epidemiology of renal cell carcinoma
19. Hypertension, antihypertensive medication and risk of renal carcinoma in California Seventh-Day Adventists
20. The risk of endometrial cancer in diabetic and hypertensive patients: A nationwide record-linkage study in Finland
21. A case-control study on risk factors for uterine endometrial cancer in Japan
22. Cigarette smoking, obesity, diuretic use and coffee consumption as risk factors for renal cell carcinoma
23. Antihypertensive therapy and the risk of malignancies
24. Do calcium channel blockers increase the risk of cancer?
25. Calcium-channel blockade and incidence of cancer in aged populations
26. Use of calcium channel blockers and breast carcinoma risk in postmenopausal women
27. Effects of calcium antagonists on the risks of coronary heart disease, cancer and bleeding
28. Relation between drug treatment and cancer in hypertensives in the Swedish trial in old patients with hypertension 2: A 5-year, prospective, randomised, controlled trial
29. Does hypertension increase mortality risk from lung cancer? A prospective cohort study on smoking, hypertension and lung cancer risk among Korean men
30. Hypertension and long-term cancer incidence and mortality among Swedish men
31. Hypertension related to DANN repair synthesis and carcinogen uptake
32. Chromosome aberrations incuded by; 7:12-dimethyl-benz[a]-anthracene in bone marrow cells of spontaneously hypertensive rats (SHR) and control Wistar Kyoto (WKY) rats: Time course and site specificity
33. Apoptosis (The 1992 Frank Rose Memorial Lecture)
34. Cell death by apoptosis and its protective role against disease
35. Calcium channel blockers and cancer: Is an association biologically plausible?
36. Apoptosis, in pressure overload-induced heart hypertrophy in the rat
37. Apoptosis in target organs of hypertension
38. 2+ in toxic cell killing
39. Calcium channel blockers, apoptosis and cancer: Is there a biologic relationship?
40. The biosynthesis of hormones by nonendocrine tumours
41. Glycopeptide hormones and neoplasms
42. Secular trends in long-term sustained hypertension, long-term treatment and cardiovascular mortality. The Framingham Heart Study 1950 to 1990